Records containing: Influenza
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2009-01-08Study 181-1-06-01 - Phase 1A Clinical Study With DAS181: Double-Blind, Randomized, Placebo-Controlled, Single Dose Escalating Study in Healthy Adults
-
CLINICAL_TRIALS study record update · 2008-12-08Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months
-
CLINICAL_TRIALS study record update · 2008-12-04A Phase III, Single-blind, Randomized Study to Evaluate the Immunogenicity and Safety of Fluarix® (GSK Biologicals') Compared With Fluzone® (Aventis Pasteur/Sanofi) Administered Intramuscularly in Children (6 Months and Older)
-
CLINICAL_TRIALS study record update · 2008-11-26Pilot Study to Develop a Model to Evaluate Nosocomial Transmission of Influenza
-
CLINICAL_TRIALS study record update · 2008-11-24Open-Label Study of Intramuscular Inactivated Influenza A/H5N1 Vaccine in Healthy Children Aged 2 Years to 10 Years
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2008-11-20A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)
-
CLINICAL_TRIALS study record update · 2008-11-18Type 1 Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally
-
CLINICAL_TRIALS study record update · 2008-11-10A Single-Site, Phase 1/2, Double-Blind, Safety and Immunogenicity Trial of an Alphavirus Replicon Vaccine Expressing Influenza A/Wyoming/03/2003 Hemagglutinin (AVX502) in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2008-11-10Phase I Inpatient Study of the Safety and Immunogenicity of Live Influenza A Vaccine H2N2 (A/Ann Arbor/6/60 ca Recombinant), a Live Attenuated Virus Vaccine Candidate for Prevention of Influenza H2N2 Infection in the Event of a Pandemic
-
CLINICAL_TRIALS study record update · 2008-10-09Efficacy of Influenza Vaccine in HIV Infected Adults
-
CLINICAL_TRIALS study record update · 2008-10-09Influenza Vaccination at a Reduced Dose of 1:10 Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, Jerusalem
-
CLINICAL_TRIALS study record update · 2008-09-22A Phase IV Study to Evaluate the Effectiveness of Flumist (Influenza Vaccine, Live Intranasal) Vaccination in a School-Based Intervention Program
-
CLINICAL_TRIALS study record update · 2008-08-13Immunogenicity, Reactogenicity and Safety of the Trivalent Influenza Subunit Vaccine Influvac® for the Season 2008/2009. An Open-Label, Baseline-Controlled Multi-Center Study in Two Groups: Adult Subjects and Elderly Subjects
-
CLINICAL_TRIALS study record update · 2008-08-08Comparative Vaccination Study of the Reactogenicity and Immunogenicity of a Thiomersal-Free Formulation of Influsplit SSW® 2002/2003 Versus the Standard Formulation of Influsplit SSW® 2002/2003 in Individuals Over 18 Years
-
CLINICAL_TRIALS study record update · 2008-07-24A Prospective, Randomized, Open-Label Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With Trivalent Inactivated Vaccine (TIV) in Children 6 to <36 Months of Age
-
CLINICAL_TRIALS study record update · 2008-05-30Prospective Study of Individuals Exposed to Confirmed Cases of Human Influenza A (H5N1) Infection in China
-
CLINICAL_TRIALS study record update · 2008-05-30Matched Case-Control Study of Risk Factors for Human Infection With Avian Influenza A (H5N1) Virus, China
-
CLINICAL_TRIALS study record update · 2008-04-24A Phase III, Randomized, Controlled, Observer-Blind, Multicenter Study to Evaluate the Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects
-
CLINICAL_TRIALS study record update · 2008-02-18Pomegranate Products for Prevention of Common Cold and Influenza-Like Symptoms: A Double- Blind, Placebo-Controlled Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2008-02-12Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses
-
CLINICAL_TRIALS study record update · 2008-02-08A Randomized, Placebo-Controlled, Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, (MMRIIÒ) and Varicella (VARIVAXÒ) Vaccines Administered Concurrently to Healthy Children (AV018)
-
CLINICAL_TRIALS study record update · 2008-01-30A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAMUSCULAR PERAMIVIR IN SUBJECTS WITH UNCOMPLICATED ACUTE INFLUENZA
-
CLINICAL_TRIALS study record update · 2008-01-28Comparison of Swab Types for Specimen Collection
-
CLINICAL_TRIALS study record update · 2008-01-21Phase 1 Inpatient Study of the Safety and Immunogenicity of H9N2 (6-2) AA ca Reassortant (A/Chicken/Hong Kong/G9/97 x A/Ann Arbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for Prevention of Avian Influenza H9N2 Infection in the Event of a Pandemic (Study B)
-
CLINICAL_TRIALS study record update · 2008-01-21Phase I Inpatient Study of the Safety and Immunogenicity of H9N2 (6-2) AA ca Reassortant (A/Chicken/Hong Kong/G9/97 x A/Ann Arbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for Prevention of Avian Influenza H9N2 Infection in the Event of a Pandemic (Study A)